Novo Nordisk and Corporate Strategy (Copenhagen)

JCI Copenhagen International invites you to our next monthly meeting:

Novo Nordisk Corporate Strategy

This month we have the pleasure of inviting you to a company visit at Novo Nordisk, where Susan Blesener will give a presentation about Novo Nordisk Corporate Strategy.

Susan Blesener is Director of Corporate Accountability at Novo Nordisk, the Danish world leader in insulin production and diabetes care, with responsibility for integrated corporate reporting which reflects multiple dimensions of performance. Novo Nordisk has produced integrated reporting since Protected content part of its process of integrated performance management, exploring the interactions between financial and non-financial performance.

The meeting will be rounded up by our chapter hour. Here you will get the latest news from JCICI inside, JCI Region/National and JCI world.

Meeting agenda:

17:45 arrival
18:00 dinner and networking
18:30 Novo Nordisk Corporate Strategy
19:30 coffee break and networking
19:45 JCICI chapter hour
21:00 networking in a close-by bar/cafe

Exact time points may vary, but we start at 18:00 sharp

Practical:

Date: Monday, May 16th Protected content 17:45
Place: Novo Nordisk, Novo Allé, Protected content
Price: 150 DKK for JCI members, Protected content for guests; meal included
Sign up: Please sign up and pay via Protected content
Make sure to register at the latest on Thursday May 12th!
Transport: Let’s go together to Bagsværd. We meet 17:00 (sharp) at the Main Station and take S-tog A (to Farum) at 17:03.
Contact: Sven Schöbel ( Protected content